Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuropharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2010.08.004PMID 20713069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GABA and Glutamate Receptor Ligands and their Therapeutic Potential in CNS Disorders

  2010cited by this paper
• Hydrophobic Side Chain Dynamics of a Glutamate Receptor Ligand Binding Domain*

  2010cited by this paper
• Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.

  2010cited by this paper
• Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.

  2010cited by this paper
• X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor

  2009cited by this paper
• Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain.

  2009cited by this paper
• A nomenclature for ligand-gated ion channels.

  2009cited by this paper
• Structure of the S1S2 glutamate binding domain of GLuR3

  2009cited by this paper
• The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature.

  2009cited by this paper
• Probing the allosteric modulator binding site of GluR2 with thiazide derivatives.

  2009cited by this paper
• Crystal structure and association behaviour of the GluR2 amino‐terminal domain

  2009cited by this paper
• Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.

  2009cited by this paper
• Ionotropic glutamate receptors & CNS disorders.

  2008cited by this paper
• LRET investigations of conformational changes in the ligand binding domain of a functional AMPA receptor.

  2008cited by this paper
• Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotency.

  2008cited by this paper
• Molecular mechanism of agonist recognition by the ligand‐binding core of the ionotropic glutamate receptor 4

  2008cited by this paper
• Structural and Single-Channel Results Indicate That the Rates of Ligand Binding Domain Closing and Opening Directly Impact AMPA Receptor Gating

  2008cited by this paper
• Chemical interplay in the mechanism of partial agonist activation in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

  2008cited by this paper
• 6-Azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor.

  2008cited by this paper
• A tetrazolyl-substituted subtype-selective AMPA receptor agonist.

  2007cited by this paper
• Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites.

  2007cited by this paper
• TARP Auxiliary Subunits Switch AMPA Receptor Antagonists into Partial Agonists

  2007cited by this paper
• Role of the chemical interactions of the agonist in controlling alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation.

  2007cited by this paper
• The free energy landscapes governing conformational changes in a glutamate receptor ligand-binding domain.

  2007cited by this paper
• AMPA receptor potentiators: application for depression and Parkinson's disease.

  2007cited by this paper
• Allosteric mechanism in AMPA receptors: A FRET-based investigation of conformational changes

  2006cited by this paper
• Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor.

  2006cited by this paper
• Developmentally regulated, combinatorial RNA processing modulates AMPA receptor biogenesis.

  2006cited by this paper
• Interdomain Interactions in AMPA and Kainate Receptors Regulate Affinity for Glutamate

  2006cited by this paper
• The structure of a mixed GluR2 ligand-binding core dimer in complex with (S)-glutamate and the antagonist (S)-NS1209.

  2006cited by this paper
• Glutamate- and GABA-based CNS therapeutics.

  2006cited by this paper
• A Binding Site Tyrosine Shapes Desensitization Kinetics and Agonist Potency at GluR2

  2005cited by this paper
• Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2.

  2005cited by this paper
• Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors

  2005cited by this paper
• Conformational Changes in the Ligand-binding Domain of a Functional Ionotropic Glutamate Receptor*

  2005cited by this paper
• Exploring the GluR2 ligand‐binding core in complex with the bicyclical AMPA analogue (S)‐4‐AHCP

  2005cited by this paper
• Tyr702 Is an Important Determinant of Agonist Binding and Domain Closure of the Ligand-Binding Core of GluR2

  2005cited by this paper
• Ionotropic and metabotropic glutamate receptor structure and pharmacology

  2005cited by this paper
• Evolution of glutamate interactions during binding to a glutamate receptor

  2005cited by this paper
• Structure of the metabotropic glutamate receptor.

  2003cited by this paper
• Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.

  2003cited by this paper
• Structural basis for partial agonist action at ionotropic glutamate receptors

  2003cited by this paper
• Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes

  2003cited by this paper
• Competitive antagonism of AMPA receptors by ligands of different classes: crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX.

  2003cited by this paper
• Three-dimensional structure of the ligand-binding core of GluR2 in complex with the agonist (S)-ATPA: implications for receptor subunit selectivity.

  2003cited by this paper
• Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists

  2003cited by this paper
• Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate.

  2002cited by this paper
• Mechanism of glutamate receptor desensitization

  2002cited by this paper
• The AMPA receptor binding site: focus on agonists and competitive antagonists.

  2002cited by this paper
• GluR2 ligand‐binding core complexes: importance of the isoxazolol moiety and 5‐substituent for the binding mode of AMPA‐type agonists

  2002cited by this paper
• 2-Amino-3-(3-hydroxy-1,2,5-thiadiazol-4-yl)propionic acid: resolution, absolute stereochemistry and enantiopharmacology at glutamate receptors.

  2002cited by this paper
• Structural mobility of the extracellular ligand-binding core of an ionotropic glutamate receptor. Analysis of NMR relaxation dynamics.

  2002cited by this paper
• Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.

  2002cited by this paper
• Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties.

  2001cited by this paper
• Resolution, configurational assignment, and enantiopharmacology at glutamate receptors of 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid (ACPA) and demethyl-ACPA.

  2001cited by this paper
• Glutamate as a neurotransmitter in the brain: review of physiology and pathology.

  2000cited by this paper
• Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.

  2000cited by this paper
• Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.

  2000cited by this paper
• The glutamate receptor ion channels.

  1999cited by this paper
• Systematic analysis of domain motions in proteins from conformational change: New results on citrate synthase and T4 lysozyme

  1998cited by this paper
• A point mutation in the glutamate binding site blocks desensitization of AMPA receptors.

  1998cited by this paper
• Structure of a glutamate-receptor ligand-binding core in complex with kainate

  1998cited by this paper
• Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct

  1998cited by this paper
• Synthesis of Willardiine and 6-Azawillardiine Analogues: Pharmacological Characterization on Cloned Homomeric Human AMPA and Kainate Receptor Subtypes.

  1998cited by this paper
• Excitatory amino-acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid

  1997cited by this paper
• Overexpression of a glutamate receptor (GluR2) ligand binding domain in Escherichia coli: application of a novel protein folding screen.

  1997cited by this paper
• AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.

  1997cited by this paper
• Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.

  1997cited by this paper
• Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.

  1997cited by this paper
• Excitatory Amino-Acid Receptor Agonists. Synthesis and Pharmacology of Analogues of 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid.

  1997cited by this paper
• Stable expression of homomeric AMPA-selective glutamate receptors in BHK cells.

  1996cited by this paper
• Drug Discovery Handbook

  1994cited by this paper
• A molecular determinant for submillisecond desensitization in glutamate receptors.

  1994cited by this paper
• Heterocyclic excitatory amino acids. Synthesis and biological activity of novel analogues of AMPA.

  1992cited by this paper
• Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.

  1990cited by this paper
• Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS.

  1990cited by this paper
• A family of AMPA-selective glutamate receptors.

  1990cited by this paper
• Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists.

  1990cited by this paper
• The pharmacology of quisqualate and AMPA in the cerebral cortex of the rat in vitro.

  1989cited by this paper
• [3H]AMPA binding to glutamate receptor subpopulations in rat brain.

  1987cited by this paper
• Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors.

  1984cited by this paper
• New class of glutamate agonist structurally related to ibotenic acid

  1980cited by this paper

• Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review

  2025cites this paper
• The positive allosteric modulator BPAM344 and L‐glutamate introduce an active‐like structure of the ligand‐binding domain of GluK2

  2024cites this paper
• GluD1 binds GABA and controls inhibitory plasticity

  2023cites this paper
• Exploring thienothiadiazine dioxides as isosteric analogues of benzo- and pyridothiadiazine dioxides in the search of new AMPA and kainate receptor positive allosteric modulators

  2023cites this paper
• Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective

  2023cites this paper
• Small molecule positive allosteric modulation of homomeric kainate receptors GluK1-3: Development of screening assays and insight into GluK3 structure

  2023cites this paper
• Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype

  2022cites this paper
• An Insight into Animal Glutamate Receptors Homolog of Arabidopsis thaliana and Their Potential Applications—A Review

  2022cites this paper
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

  2021cites this paper
• Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: a long and winding road.

  2021cites this paper
• Development of Thiochroman Dioxide Analogues of Benzothiadiazine Dioxides as New Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors.

  2021cites this paper
• Structural biology of ionotropic glutamate delta receptors and their crosstalk with metabotropic glutamate receptors.

  2021cites this paper
• Glycine agonism in ionotropic glutamate receptors.

  2021cites this paper
• OBSOLETE: Ion Channels

  2021cites this paper
• Structural biology of kainate receptors.

  2021cites this paper
• Allosteric coupling of sub-millisecond clamshell motions in ionotropic glutamate receptor ligand-binding domains

  2021cites this paper
• Quantum Chemistry Simulation of Biological Molecules

  2020cites this paper
• AMPA Receptor Surface Expression Is Regulated by S-Nitrosylation of Thorase and Transnitrosylation of NSF

  2020cites this paper
• Binding of a negative allosteric modulator and competitive antagonist can occur simultaneously at the ionotropic glutamate receptor GluA2

  2020cites this paper
• The ionotropic glutamate receptor GluA2 in complex with bicyclic pyrimidinedione-based compounds: when small compound modifications have distinct effects on binding interactions.

  2020cites this paper
• Architecture and function of NMDA receptors: an evolutionary perspective

  2020cites this paper
• Structure of the Arabidopsis Glutamate Receptor-like Channel GLR3.2 Ligand-Binding Domain.

  2020cites this paper
• Structural Mechanisms Underlying Activity Changes in an AMPA-type Glutamate Receptor Induced by Substitutions in Its Ligand-Binding Domain.

  2019cites this paper
• Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.

  2019cites this paper
• N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.

  2019cites this paper
• Mapping the Conformational Landscape of Glutamate Receptors Using Single Molecule FRET.

  2019cites this paper
• Druggability Simulations and X-Ray Crystallography Reveal a Ligand-Binding Site in the GluA3 AMPA Receptor N-Terminal Domain.

  2019influential citation
• Noncompetitive antagonists induce cooperative AMPA receptor channel gating

  2019cites this paper
• Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases.

  2019cites this paper
• Quinoxalinedione deprotonation is important for glutamate receptor binding

  2019cites this paper
• The GluN2B‐Glu413Gly NMDA receptor variant arising from a de novo GRIN2B mutation promotes ligand‐unbinding and domain opening

  2018cites this paper
• Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds.

  2018cites this paper
• Crystal Structures of Potent Dimeric Positive Allosteric Modulators at the Ligand-Binding Domain of the GluA2 Receptor.

  2018cites this paper
• Structure, function, and allosteric modulation of NMDA receptors

  2018influential citation
• An improved quantum biochemistry description of the glutamate–GluA2 receptor binding within an inhomogeneous dielectric function framework

  2017cites this paper
• NMDA Receptors in the Central Nervous System.

  2017cites this paper
• Structural and Functional Architecture of AMPA-Type Glutamate Receptors and Their Auxiliary Proteins.

  2017cites this paper
• Structure and symmetry inform gating principles of ionotropic glutamate receptors

  2017cites this paper
• Glutamate Receptor-Like Ion Channels in Arabidopsis thaliana

  2017cites this paper
• The Challenge of Interpreting Glutamate-Receptor Ion-Channel Structures.

  2017cites this paper
• Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.

  2017cites this paper
• Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors

  2017cites this paper
• Aryl‐ and heteroaryl‐substituted phenylalanines as AMPA receptor ligands

  2017cites this paper
• Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors.

  2017cites this paper
• The Structure of a High-Affinity Kainate Receptor: GluK4 Ligand-Binding Domain Crystallized with Kainate.

  2016cites this paper
• Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 Receptors

  2016cites this paper
• Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA Receptors.

  2016cites this paper
• Studies on Aryl-Substituted Phenylalanines: Synthesis, Activity, and Different Binding Modes at AMPA Receptors.

  2016cites this paper
• Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues.

  2016cites this paper
• AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications.

  2015cites this paper
• Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1.

  2015cites this paper
• A quantum biochemistry investigation of willardiine partial agonism in AMPA receptors.

  2015cites this paper
• Structure − Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist ( 2 S , 3 R ) ‐ 3-( 3-Carboxyphenyl ) pyrrolidine-2-carboxylic Acid

  2015cites this paper
• GluD2: GluD2 receptors containing the lurcher mutation iGluRs: Ionotropic glutamate receptors ITC: Isothermal titration calorimetry LBD: Ligand binding domain LTP: Long-term potentiation LTD: Long-term depression NMDA: N-methyl-D-aspartate NMDAR: NMDA receptor PSD: Postsynaptic density SAR: Structur

  2015cites this paper
• L‐Asp is a useful tool in the purification of the ionotropic glutamate receptor A2 ligand‐binding domain

  2014cites this paper
• Computational Approaches in Molecular and Systems Pharmacology: Application to Neurosignaling Membrane Proteins

  2014cites this paper
• NMDA receptor structures reveal subunit arrangement and pore architecture

  2014cites this paper
• Role of Stoichiometry in the Dimer-Stabilizing Effect of AMPA Receptor Allosteric Modulators

  2013cites this paper
• Structural analysis of the positive AMPA receptor modulators CX516 and Me-CX516 in complex with the GluA2 ligand-binding domain.

  2013cites this paper
• Functional insights from glutamate receptor ion channel structures.

  2013cites this paper
• Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization.

  2013cites this paper
• Structural Dynamics and Allosteric Signaling in Ionotropic Glutamate Receptors

  2013cites this paper
• Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold.

  2013cites this paper
• A conformational intermediate in glutamate receptor activation.

  2013cites this paper
• An ab initio explanation of the activation and antagonism strength of an AMPA-sensitive glutamate receptor

  2013cites this paper
• Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.

  2013cites this paper
• Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics.

  2013cites this paper
• Computational Study of Synthetic Agonist Ligands of Ionotropic Glutamate Receptors

  2013cites this paper
• Proteins and azobenzenes

  2013cites this paper
• Structural and Pharmacological Characterization of Phenylalanine‐Based AMPA Receptor Antagonists at Kainate Receptors

  2012cites this paper
• Ligand-gated ion channels: new insights into neurological disorders and ligand recognition.

  2012cites this paper
• Kainate induces various domain closures in AMPA and kainate receptors.

  2012influential citation
• Glutamate Receptor Homologs in Plants: Functions and Evolutionary Origins

  2012cites this paper
• Molecular Determinants of Subtype-selective Efficacies of Cytisine and the Novel Compound NS3861 at Heteromeric Nicotinic Acetylcholine Receptors*

  2012cites this paper
• Synaptic neurotransmitter-gated receptors.

  2012cites this paper
• Pharmacological and structural characterization of conformationally restricted (S)-glutamate analogues at ionotropic glutamate receptors.

  2012cites this paper
• Structure and mechanism of glutamate receptor ion channel assembly, activation and modulation.

  2011cites this paper
• Resolution of controversies in drug/receptor interactions by protein structure. Limitations and pharmacological solutions.

  2011cites this paper
• Emerging models of glutamate receptor ion channel structure and function.

  2011influential citation
• Ionotropic Glutamate Receptors (iGluRs): Overview of iGluR2 ligand binding domain in complex with agonists and antagonists

  2011cites this paper
• Glutamate receptor ion channels: where do all the calories go?

  2011cites this paper
• A new phenylalanine derivative acts as an antagonist at the AMPA receptor GluA2 and introduces partial domain closure: synthesis, resolution, pharmacology, and crystal structure.

  2011cites this paper
• Crystal structures of the glutamate receptor ion channel GluK3 and GluK5 amino-terminal domains.

  2010cites this paper